Leukemia survival rates prior and after introduction of Imatinib

Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)*

by Statista Research Department, last edited Apr 30, 2015
Leukemia survival rates prior and after introduction of Imatinib This statistic shows the leukemia patients survival rates before and after introduction of drug Imatinib, over a period of five years. The survival rate has increased drastically from 31 percent up to 89 percent.
Show more

Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Amgen"
  • Global positioning
The most important statistics
  • Revenue and income
  • Expenditure
  • Other key figures
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.